4FIRE(@netcreat):#QNT Quantinuum surged more than 27% today, and I believe the biggest catalyst was its deal with Oracle. Here is how I view the deal. Personally, I sincerely hope this partnership succeeds and becomes the first clear example of meaningful synergy between quantum computing and HPC. If it does, it could become an important proof point for the entire industry and help drive the quantum ecosystem forward with much greater momentum. Having said that, there are still clear technical and commercial challenges that should not be overlooked. Helios can be offered to real customers. That has already been demonstrated. It is an existing cloud-accessible quantum system. But the next question is very different: Why should customers actually use Helios through OCI? So if the question is, “Can Quantinuum technically offer Helios as a service through OCI?” my answer is yes. But if the question is, “Will Oracle customers now have access to 48 fault-tolerant logical qubits operating at 99.999% fidelity?” my answer is much closer to no. At least, that is not what the currently published technical results demonstrate. In the 48-LQ QEC-cycle experiment, 5,000 shots were submitted for each basis. After the various selection stages, the final accepted samples were: X basis: 708 / 5,000 ≈ 14.2% Z basis: 958 / 5,000 ≈ 19.2% (attached pre-print link and the screenshot below) https://t.co/TmdBPeLmGP That is why I think we need to distinguish between validation of Quantinuum’s technology and commercial validation of its economic usefulness. Oracle putting Helios inside its data center → meaningful validation. Oracle putting Helios inside its data center → proof that Helios already has production workloads that outperform AI/HPC → not demonstrated yet. What matters next will be what happens after the OCI preview begins: paying customers, QPU utilization, bookings and revenue, repeat usage, and most importantly, which real workloads actually benefit from combining QPUs with GPUs/HPC. Once those numbers begin to emerge, we will have a much better idea whether the Oracle deal is primarily a strategic option on quantum computing, or a genuine commercialization inflection point that could take Quantinuum beyond the current AWS Braket/Azure Quantum model. There is another factor worth considering when looking at today's 27% move: QNT's market structure. Quantinuum has only recently gone public. It has roughly 261 million shares outstanding, but a float of only around 31 million shares. That distinction matters. The contrast with IonQ is striking. IonQ generated $80.1M of Q2 revenue versus Quantinuum's $8.0M — roughly 10× as much. The midpoint of their FY2026 revenue guidance is similarly about $285M vs. $30M, or roughly 9.5×. Yet their market capitalizations are now in roughly the same range, with Quantinuum at times valued even higher. On a very simple forward P/S basis, that works out to approximately: IonQ: ~55× Quantinuum: ~600× In other words, Quantinuum is currently receiving a revenue-multiple premium of roughly 10× over IonQ. Liquidity is also very different. QNT's normal daily trading volume has been only around 1.35–1.46 million shares, while IonQ trades with substantially greater liquidity. With such a small float, a combination of Oracle + earnings + QEC headlines can produce a very large price response. So I would be cautious about concluding that “the market has decided Quantinuum is worth more than IonQ.” With this kind of float and liquidity, the price can potentially be moved disproportionately by a relatively small portion of market participants. The numbers are rather extreme: IonQ generates roughly 10× Quantinuum's revenue, yet the two companies are trading at roughly comparable valuations. That does not necessarily mean the market is wrong about Quantinuum's technological potential. It does mean that I would be very careful about interpreting the current stock price as a clean measure of broad market consensus. I have a hard enough time predicting IonQ's sharp moves up and down. With a stock this lightly traded, I have even less confidence trying to predict QNT's price action — especially when so much of its valuation still depends on outcomes that remain well into the future.

2026.08.13 01:04

#QNT# Quantinuum surged more than 27% today, and I believe the biggest catalyst was its deal with Oracle. Here is how I view the deal. Personally, I sincerely hope this partnership succeeds and becomes the first clear example of meaningful synergy between quantum computing and HPC. If it does, it could become an important proof point for the entire industry and help drive the quantum ecosystem forward with much greater momentum. Having said that, there are still clear technical and commercial challenges that should not be overlooked. Helios can be offered to real customers. That has already been demonstrated. It is an existing cloud-accessible quantum system. But the next question is very different: Why should customers actually use Helios through OCI? So if the question is, “Can Quantinuum technically offer Helios as a service through OCI?” my answer is yes. But if the question is, “Will Oracle customers now have access to 48 fault-tolerant logical qubits operating at 99.999% fidelity?” my answer is much closer to no. At least, that is not what the currently published technical results demonstrate. In the 48-LQ QEC-cycle experiment, 5,000 shots were submitted for each basis. After the various selection stages, the final accepted samples were: X basis: 708 / 5,000 ≈ 14.2% Z basis: 958 / 5,000 ≈ 19.2% (attached pre-print link and the screenshot below) That is why I think we need to distinguish between validation of Quantinuum’s technology and commercial validation of its economic usefulness. Oracle putting Helios inside its data center → meaningful validation. Oracle putting Helios inside its data center → proof that Helios already has production workloads that outperform AI/HPC → not demonstrated yet. What matters next will be what happens after the OCI preview begins: paying customers, QPU utilization, bookings and revenue, repeat usage, and most importantly, which real workloads actually benefit from combining QPUs with GPUs/HPC. Once those numbers begin to emerge, we will have a much better idea whether the Oracle deal is primarily a strategic option on quantum computing, or a genuine commercialization inflection point that could take Quantinuum beyond the current AWS Braket/Azure Quantum model. There is another factor worth considering when looking at today's 27% move: QNT's market structure. Quantinuum has only recently gone public. It has roughly 261 million shares outstanding, but a float of only around 31 million shares. That distinction matters. The contrast with IonQ is striking. IonQ generated $80.1M of Q2 revenue versus Quantinuum's $8.0M — roughly 10× as much. The midpoint of their FY2026 revenue guidance is similarly about $285M vs. $30M, or roughly 9.5×. Yet their market capitalizations are now in roughly the same range, with Quantinuum at times valued even higher. On a very simple forward P/S basis, that works out to approximately: IonQ: ~55× Quantinuum: ~600× In other words, Quantinuum is currently receiving a revenue-multiple premium of roughly 10× over IonQ. Liquidity is also very different. QNT's normal daily trading volume has been only around 1.35–1.46 million shares, while IonQ trades with substantially greater liquidity. With such a small float, a combination of Oracle + earnings + QEC headlines can produce a very large price response. So I would be cautious about concluding that “the market has decided Quantinuum is worth more than IonQ.” With this kind of float and liquidity, the price can potentially be moved disproportionately by a relatively small portion of market participants. The numbers are rather extreme: IonQ generates roughly 10× Quantinuum's revenue, yet the two companies are trading at roughly comparable valuations. That does not necessarily mean the market is wrong about Quantinuum's technological potential. It does mean that I would be very careful about interpreting the current stock price as a clean measure of broad market consensus. I have a hard enough time predicting IonQ's sharp moves up and down. With a stock this lightly traded, I have even less confidence trying to predict QNT's price action — especially when so much of its valuation still depends on outcomes that remain well into the future.

4FIRE@netcreat

2026.08.12 12:50

The Uncomfortable Truth Behind Quantinuum’s Earnings and Its “Near Five-Nines” Claim. Disclaimer: This post is not intended to discredit Quantinuum or favor any particular company. My concern is simply that many investors make investment decisions—or repeat claims in discussions—without understanding the underlying facts and technical context. The purpose here is to look beyond the headlines and clarify what was actually demonstrated. Quantinuum has been at essentially the same physical-gate fidelity level for years. In 2023, its H-Series was already around 99.997% 1Q fidelity and roughly 99.8% 2Q fidelity. By late 2025, Helios reported 99.9975% 1Q and 99.921% 2Q. The improvement is real, but incremental. Helios’ published hardware benchmark reports those latter figures directly. The bigger headline has been logical qubits: Quantinuum has promoted 94 error-detected LQs (it doesn't mean the error is corrected) and 48 error-corrected LQs from just 98 physical qubits. Now it is advertising “near five-nines” logical fidelity. But the underlying result is about 99.996% logical QEC-cycle fidelity, and the experiment still uses post-selection—detected bad outcomes are excluded, and the fidelity is evaluated on the accepted shots. That is still a meaningful QEC result. But it is not the same thing as demonstrating 99.999% universal logical-gate fidelity, nor is it equivalent to 48 utility-scale fault-tolerant logical qubits. The headline sounds much stronger than what was actually demonstrated.

Forward to community